Close
ACHEMA MIDDLE EAST 2026

BenevolentAI and AstraZeneca expand drug discovery partnership

BenevolentAI and AstraZeneca have announced the expansion of their artificial intelligence (AI)-powered drug discovery partnership to include disease areas, systemic lupus erythematosus (SLE) and...

Tevogen Bio Further Strengthens IP Portfolio With Additional Patent for Method of Preparing Its Investigational SARS-CoV-2 Specific T cell Therapy

Tevogen Bio, a clinical stage biotechnology company specializing in cell and gene therapies in oncology and viral infections, announced that the U.S. Patent and...

Half-Million COVID Antibody Doses Sold By AstraZeneca To US

After topping off supplies to Pfizer and GlaxoSmithkline, of the COVID-19 vaccine, US has sought AstraZeneca’s help of its antibody combo. Notably, the government...

Ensovibep Therepeutic Candidate To Fight COVID-19 Makes Way

The phase 2 EMPATHY top-line data which is a DARP in therapeutic antiviral used in the COVID-19 treatment suggests that measurable and meaningful benefits...

As Per WHO Omicron To Affect Above 50% of Europe In 2 Months

According to the forecast shared by WHO top officials more than half of Europe will suffer from the highly contagious variant of COVID-19, Omicron...

Eagle Genomics and Quadram Institute’s New Strategic Partnership to Accelerate Microbiome Analysis Through AI-Augmented Knowledge Discovery Platform

Eagle Genomics, the Deep Tech software business pioneering the application of network science to biology, and the Quadram Institute, a world-leading institute creating new...

Cystic Fibrosis Treatment for 6-11 Years Old Gets A Nod

When it comes to cystic fibrosis, which is a debilitating and progressive condition found in around 11000 people in the UK, no cure has...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...